2026-03-27T13:05:41-05:00 2025-06-30 760722072 FOUMBERG JUNEJA ROCHER & CO PC 16311 VENTURA BLVD SUITE 1180 ENCINO CA 91436 990 2024-07-01 561683450 SOLVE ME CFS INITIATIVE INC SOLV 7043640016 12100 WILSHIRE BLVD 800 LOS ANGELES CA 90025 EMILY TAYLOR PRESIDENT/CEO 7043640016 2026-03-26 1 1 MARK A LUCHT CPA P00112942 8189816100 2026-03-26 2024 2025-03-06 01:10:19Z EMILY TAYLOR 12100 WILSHIRE BLVD 800 LOS ANGELES CA 90025 2091506 0 X WWW.SOLVECFS.ORG X 1987 CA MAKE ME/CFS, LONG COVID AND OTHER POST-INFECTION DISEASES WIDELY UNDERSTOOD, DIAGNOSABLE, AND TREATABLE. 16 15 11 1688 0 0 1911527 2071530 0 0 35579 19976 0 0 1947106 2091506 158718 142438 0 0 1390444 960827 0 0 473608 1297844 789786 2847006 1893051 -899900 198455 1074263 1110180 313990 151452 760273 958728 X THE SOLVE ME/CFS INITIATIVE (SOLVE M.E.) IS A NON-PROFIT ORGANIZATION THAT SERVES AS A CATALYST FOR CRITICAL RESEARCH INTO DIAGNOSTICS, TREATMENTS, AND CURES FOR MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS), LONG COVID AND OTHER (CONTINUED ON SCH. O) POST-INFECTION DISEASES. OUR WORK WITH THE SCIENTIFIC, MEDICAL, AND PHARMACEUTICAL COMMUNITIES, ADVOCACY WITH GOVERNMENT AGENCIES, AND ALLIANCES WITH PATIENT GROUPS AROUND THE WORLD ARE LAYING THE FOUNDATION FOR BREAKTHROUGHS THAT CAN IMPROVE THE LIVES OF MILLIONS WHO SUFFER FROM VARIOUS ''LONG HAUL'' DISEASES. 0 0 645399 73788 ADVOCACY AND COMMUNICATION ACCOMPLISHMENTS: IN 2025, SOLVE M.E. ADVANCED NATIONAL AWARENESS AND POLICY MOMENTUM FOR ME/CFS AND LONG COVID THROUGH COORDINATED FEDERAL ADVOCACY AND COMMUNITY ENGAGEMENT. DURING ADVOCACY WEEK 2025, MORE THAN 3,500 ADVOCATE EMAILS, CALLS, AND TEXTS WERE SENT TO MEMBERS OF CONGRESS TO SUSTAIN THE CDC CHRONIC FATIGUE SYNDROME PROGRAM AND ENSURE ME/CFS REMAINED ELIGIBLE UNDER THE DEPARTMENT OF DEFENSE CDMRP PROGRAM. EMILY TAYLOR, MONIQUE WIKE, AND VOLUNTEERS MET WITH OVER TWENTY CONGRESSIONAL OFFICES IN WASHINGTON, D.C., SECURING BIPARTISAN SUPPORT, WITH 11 SENATORS JOINING THE CDC DEAR COLLEAGUE LETTER AND 10 SENATORS SUPPORTING THE CDMRP REQUEST. SOLVE MAINTAINED A STRONG NON-PARTISAN STRATEGY TO KEEP RESEARCH AND PROGRAM FUNDING VIABLE ACROSS ADMINISTRATIONS. (CONTINUED ON SCH. O) EMILY TAYLOR CO-AUTHORED A WHITE PAPER PROPOSING NIH RESTRUCTURING TO BETTER SUPPORT INFECTION-ASSOCIATED CHRONIC CONDITIONS AND COLLABORATED ON THREE MAJOR RECOVER PUBLICATIONS ADVANCING SCIENTIFIC AND POLICY UNDERSTANDING. THROUGH ITS PARTNERSHIP WITH MEACTION ON THE GO LOCAL CAMPAIGN, THE LIVED EXPERIENCE TASK FORCE MICROGRANT PROGRAM, AND EDUCATIONAL WEBINARS WITH THE BATEMAN HORNE CENTER, SOLVE CONTINUED TO EXPAND GRASSROOTS LEADERSHIP, EDUCATION, AND FEDERAL ENGAGEMENT, FURTHER ELEVATING THE PATIENT VOICE IN NATIONAL DECISION-MAKING. THE SUCCESSFUL INCLUSION OF ME/CFS WITHIN THE CDMRP RESULTED IN MORE THAN $300 MILLION IN POTENTIAL RESEARCH FUNDING OPPORTUNITIES, MARKING A MAJOR MILESTONE FOR THE COMMUNITY AND THE FIELD. 517700 68650 RESARCH ACCOMPLISHMENTS: SOLVE'S RESEARCH INITIATIVES ACHIEVED MAJOR MILESTONES THIS YEAR THROUGH NEW AWARDS, PARTNERSHIPS, AND PLATFORM DEVELOPMENT. THE ORGANIZATION LAUNCHED A $30,000 CATALYST FUND AT YALE TO SUPPORT DR. AKIKO IWASAKI'S PIONEERING ME/CFS AND LONG COVID RESEARCH, AND PROVIDED A $37,000 CATALYST AWARD TO SIMMARON RESEARCH FOR ITS RAPAMYCIN TRIAL. ADDITIONAL RAMSAY AWARDS SUPPORTED PROJECTS BY DR. DANA YELIN AND THE UNIVERSITY COLLEGE LONDON TEAM LED BY PROFESSOR CAMBRIDGE, ENSURING CONTINUED ENGAGEMENT THROUGH PUBLIC WEBINARS AND OUTREACH. SOLVE FORMALIZED THE BIC/CODA ALLIANCE, ALIGNING WITH METRODORA AND CARE EVOLUTION TO BUILD AN INTEGRATED RESEARCH AND DATA-SHARING ECOSYSTEM. FOLLOWING A SUCCESSFUL PRESS LAUNCH REACHING AN ESTIMATED 140 MILLION PEOPLE, SOLVE COORDINATED (CONTINUED ON SCH. O) THE IRB TRANSITION TO METRODORA AND PREPARED FOR PEDIATRIC AND SPANISH-LANGUAGE EXPANSION OF THE PLATFORM. THE ORGANIZATION ALSO ENTERED A PARTNERSHIP WITH GENETIC ALLIANCE AND GALATEA FOR FREE BIOBANK STORAGE AND ENHANCED MEMBER DATA CONTROL THROUGH DIGITAL CABINET ACCESS. TOGETHER, THESE ACCOMPLISHMENTS REFLECT SOLVE'S DEEP COMMITMENT TO ACCELERATING RESEARCH, FOSTERING COLLABORATION, AND TRANSLATING SCIENCE INTO TANGIBLE PROGRESS FOR PATIENTS WORLDWIDE. 1163099 1 1 0 1 0 0 0 0 0 1 1 1 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 30 0 11 1 0 0 0 0 0 0 0 0 0 0 0 0 X 16 15 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA CO IL MA MI MN NC NJ NY OR PA SC UT VA X X EMILY TAYLOR 7142961661 350 N GLENDALE BLVD STE B 368 GLENDALE CA 91206 X EMILY TAYLOR PRESIDENT/CEO 36.00 0.00 X X 170466 0 8377 JOHN NICOLS CHAIR 5.00 0.00 X X 0 0 0 RICK SPROUT SECRETARY 4.00 0.00 X X 0 0 0 MIKE ATHERTON TREASURER 4.00 0.00 X X 0 0 0 BARBARA LUBASH VICE-CHAIR 4.00 0.00 X X 0 0 0 VICTORIA BOIES BOARD MEMBER 2.00 0.00 X 0 0 0 STEWART GITTELMAN BOARD MEMBER 2.00 0.00 X 0 0 0 WILLIAM HASSLER BOARD MEMBER 2.00 0.00 X 0 0 0 CAROL HEAD BOARD MEMBER 2.00 0.00 X 0 0 0 GURDYAL KALSI BOARD MEMBER 2.00 0.00 X 0 0 0 RONA KRAMER BOARD MEMBER 2.00 0.00 X 0 0 0 AMRIT SHAHZAD BOARD MEMBER 2.00 0.00 X 0 0 0 JANICE STANTON BOARD MEMBER 2.00 0.00 X 0 0 0 CYNTHIA ADINIG BOARD MEMBER 2.00 0.00 X 0 0 0 JOSEPH BARRERA BOARD MEMBER 2.00 0.00 X 0 0 0 KENYA BECKMANN BOARD MEMBER 2.00 0.00 X 0 0 0 KISTIN JACOBSON SEE SCH. O 36.00 0.00 X X 86092 0 1965 256558 0 10342 1 0 1 0 CARE EVOLUTION LLC 521 HILLSPUR RD ANN ARBOR MI 48105 SOFTWARE AND TECHONOLOGY 115000 1 12000 2059530 321736 2071530 19976 19976 2091506 0 0 19976 X 68650 68650 73788 73788 168701 84351 42176 42174 675344 415876 80002 179466 49179 30203 5918 13058 67603 40145 9695 17763 50805 50805 5625 5625 246344 156043 30547 59754 27187 24229 2003 955 18418 6945 10042 1431 133734 35414 10216 88104 3741 1496 1122 1123 17188 14036 971 2181 8819 5268 3551 1436 1436 9021 8401 620 PATIENT REGISTRY AND BI 163903 163903 PRINTING AND POSTAGE 55667 1485 54182 DUES AND SUBSCRIPTIONS 35449 25719 3314 6416 BANK AND MERCHANT FEES 12449 1522 7477 3450 1893051 1163099 256344 473608 246884 368142 141372 22503 54313 80034 2720 1436 2720 1284 628974 638217 1074263 1110180 313990 151452 313990 151452 X 649931 913056 110342 45672 760273 958728 1074263 1110180 198455 0 X X 0 1 X 1 0 X 1998397 5519863 1989833 1911527 2071530 13491150 1998397 5519863 1989833 1911527 2071530 13491150 3701455 9789695 6341 620 48048 35579 19976 110564 13601714 0.71970 0.75190 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 1 0 0 0 0 1 5625 0 0 5625 0 PART II-B, LINE 1: THE APPROPRIATIONS INVOLVED WERE: TO RESTORE CDMRP FUNDING FOR ME/CFS RESEARCH AT THE DEPARTMENT OF DEFENSE, PROTECT AND EXPAND THE CDC ME/CFS PROGRAM, FUND THE NIH ME/CFS RESEARCH ROADMAP, AND SUPPORT A FOLLOW-UP NATIONAL ACADEMIES (NASEM) REPORT ON ME/CFS. 0 22842 328 23170 21242 1600 22842 20305 937 21242 23023 -2718 20305 18030 4993 23023 1.00000 1 0 2720 1436 1284 1284 INVESTMENTS 638217 F 638217 X 2168533 77027 77027 2091506 0 2091506 1970078 77027 77027 1893051 0 1893051 PART V, LINE 4: THE PURPOSE OF THE ORGANIZATIONS ENDOWMENT FUND IS TO SECURE THE FUTURE OF SOLVE M.E AND SUPPORT ITS PROGRAMS AND OPERATIONS. PART X, LINE 2: SOLVE M.E. IS INCORPORATED AS A NONPROFIT VOLUNTARY HEALTH AGENCY UNDER THE LAWS OF THE STATE OF NORTH CAROLINA AND QUALIFIED TO TRANSACT INTRASTATE BUSINESS IN THE STATE OF CALIFORNIA. FURTHER, SOLVE M.E. IS EXEMPT FROM FEDERAL INCOME TAX AS AN ORGANIZATION DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (THE ?CODE?) AND QUALIFIES AS A PUBLIC CHARITY UNDER CODE SECTIONS 509(A)(1) AND 170(B)(1)(A)(VI). ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED 'MORE LIKELY THAN NOT' TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR TAX LIABILITY IS NOT NECESSARY AT JUNE 30, 2025. GENERALLY, SOLVE M.E.'S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION FOR A PERIOD OF THREE (FEDERAL) OR FOUR (STATE OF CALIFORNIA) YEARS FROM THE DATE OF FILING. 1 MIDDLE EAST AND NORTH AFRICA 0 0 GRANTMAKING GRANT TO RECIPIENTS LOCATED IN THE REGION 37191 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTMAKING GRANT TO RECIPIENTS LOCATED IN THE REGION 36597 0 0 0 0 0 0 73788 0 73788 MIDDLE EAST AND NORTH AFRICA MEDICAL RESEARCH 37191 WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) MEDICAL RESEARCH 36597 WIRE 0 0 0 0 0 0 0 PART I, LINE 2: RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS. 1 SIMMARON RESEARCH INC 948 INCLINE WAY INCLINE VILLAGE NV 89451 452191464 501C3 37000 0 RAMSEY RESEARCH GRANT YALE UNIVERSTIRY PO BOX 208239 NEW HAVEN CT 06520 060646973 501C3 30000 0 CATALYST AWARD 2 1 PART I, LINE 2: RESEARCH GRANTEES ARE REQUIRED TO SUBMIT INTERIM REPORTS ON RESEARCH PROGRESS AND FINDINGS. X X X 0 0 0 0 0 0 0 0 0 EMILY TAYLOR PRESIDENT/CEO 170466 0 0 0 0 0 4831 0 3546 0 178843 0 0 0 X 2 321736 FMV 0 0 0 PART I, COLUMN (B): THIS FIGURE REFLECTS THE TOTAL NUMBER OF CONTRIBUTORS. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE COMMITTEE IS RESPONSIBLE FOR REVIEWING THE ORGANIZATION'S FORM 990 AND PROVIDING COMMENTS PRIOR TO IT BEING SUBMITTED TO THE INTERNAL REVENUE SERVICE. ALL MEMBERS OF THE BOARD OF DIRECTORS RECEIVE A COPY OF THE REVIEWED FORM 990 PRIOR TO ITS SUBMISSION TO THE IRS, BUT ARE NOT REQUIRED TO PROVIDE COMMENTS FORM 990, PART VI, SECTION B, LINE 12C DIRECTORS ARE REQUIRED TO SIGN ANNUAL CONFLICTS OF INTEREST FORMS, NOTIFY THE ORGANIZATION OF ANY CONFLICTS OF INTEREST AND RECUSE THEMSELVES FROM DISCUSSING OR VOTING ON ANY MATTERS WHICH ARE A CONFLICT FOR THEM. FORM 990, PART VI, SECTION B, LINE 15 EMPLOYEES OF THE ORGANIZATION UNDERGO PERIODIC PERFORMANCE AND COMPENSATION REVIEWS. COMPENSATION LEVEL IS DETERMINED UPON PERFORMANCE, MARKET AND THE FINANCIAL POSITION OF THE ORGANIZATION. THE PRESIDENT PERFORMS ALL REVIEWS EXCEPT FOR THE POSITION OF PRESIDENT WHICH IS DONE BY MEMBERS OF THE PROFESSIONAL STAFF RECRUITING AND COMPENSATION COMMITTEE. THIS COMMITTEE IS COMPRISED OF THE EXECUTIVE COMMITTEE OF THE BOARD. TO ENSURE SALARY COMPENSATION IS COMPARABLE TO SIMILAR ORGANIZATIONS, THE COMMITTEE CONSULTS WITH PUBLISHED SALARY SURVEYS. FORM 990, PART VI, SECTION B, LINE 15B: THE PROCESS FOR DETERMINING THE COMPENSATION FOR THE KEY EMPLOYEE IS THE SAME AS DESCRIBED ABOVE ON LINE 15A. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S FORM 990 AND ANNUAL REPORT ARE AVAILABLE ON ITS WEBSITE WWW.SOLVECFS.ORG. THE 990 IS ALSO AVAILABLE ON GUIDESTAR. UPON REQUEST THE ORGANIZATION WILL MAKE AVAILABLE COPIES OF ITS AUDITED FINANCIAL STATEMENTS, FORM 1023, GOVERNING BY-LAWS AND CONFLICTS OF INTEREST POLICY. FORM 990, PART VII, SECTION A, LINE 1: KRISTIN JACOBSON SERVED AS PRESIDENT/CEO FROM NOVEMBER 2023 TO MARCH 2024. SHE DEPARTED FROM THE ORGANIZATION AFTER MARCH 2024. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL FEES: PROGRAM SERVICE EXPENSES 156,043. MANAGEMENT AND GENERAL EXPENSES 30,547. FUNDRAISING EXPENSES 59,754. TOTAL EXPENSES 246,344. FORM 990, PART XII, LINE 2C: THE PROCESS REMAINS THE SAME AS PRIOR YEAR.